JHS Svendgaard Laboratories Ltd

JHS Svendgaard Laboratories Ltd, a player in the FMCG sector, recorded a new 52-week low of Rs.8.97 today, marking a significant decline in its stock price amid ongoing market pressures and company-specific challenges.

JHS Svendgaard Laboratories Ltd has touched a fresh 52-week low of Rs.9.04 today, marking a significant decline in its share price amid a sustained downward trend over recent sessions. The stock has underperformed its sector and broader market indices, reflecting ongoing concerns about its financial health and market positioning.

JHS Svendgaard Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Nov 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 06 January 2026, providing investors with the latest insights into its performance and prospects.

JHS Svendgaard Laboratories Ltd’s stock declined to a fresh 52-week low of Rs.9.17 today, marking a significant downturn amid continued underperformance relative to its sector and benchmark indices.

JHS Svendgaard Laboratories Ltd’s stock declined to a fresh 52-week low of Rs.9.36 today, marking a significant downturn amid ongoing pressures in the FMCG sector. Despite outperforming its sector peers by 3.42% on the day, the stock remains substantially below its previous highs and continues to reflect underlying financial and market challenges.

JHS Svendgaard Laboratories Ltd has declined to a fresh 52-week low, closing near Rs 9.52, marking a significant downturn in the stock’s performance over the past year. This new low reflects ongoing challenges faced by the company within the FMCG sector, as it continues to underperform against key benchmarks and sector averages.

JHS Svendgaard Laboratories Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 13 Nov 2024. However, the analysis and financial metrics presented here reflect the stock's current position as of 25 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

JHS Svendgaard Laboratories has reached a new 52-week low of Rs.9.8 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures within the FMCG segment.

JHS Svendgaard Laboratories has reached a new 52-week low, with its share price touching Rs.9.83 today. This marks a significant decline for the FMCG company amid broader market fluctuations and ongoing financial pressures.

JHS Svendgaard Laboratories has reached a fresh 52-week low, closing near ₹9.9, marking a significant price level that reflects ongoing challenges within the FMCG sector. The stock's recent performance contrasts sharply with broader market trends and highlights persistent pressures on the company’s financial metrics.

Shares of JHS Svendgaard Laboratories have declined to a fresh 52-week low, closing near Rs 9.9, marking a significant milestone in the stock's ongoing downward trajectory. This development comes amid a series of consecutive sessions with negative returns and persistent underperformance relative to broader market indices.

JHS Sven.Lab., a microcap player in the FMCG sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. The stock’s recent performance and fundamental indicators highlight a cautious stance among investors as the company navigates a difficult operating environment.

JHS Svendgaard Laboratories Ltd., the Himachal Pradesh-based oral care products manufacturer, reported a quarterly loss of ₹0.20 crores in Q2 FY26, marking a sharp reversal from the ₹1.06 crores profit recorded in the previous quarter. Despite achieving revenue growth of 13.21% year-on-year to ₹22.28 crores, the company's inability to convert top-line expansion into profitability continues to plague its financial performance. With a market capitalisation of just ₹102 crores and the stock trading at ₹11.80—down 46.85% over the past year—investor sentiment remains deeply pessimistic towards this micro-cap FMCG player.